|
"yen c j"的相關文件
顯示項目 391-440 / 471 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2018 |
Exposure–response relationship of ramucirumab in East Asian patients from RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer
|
Kim, T.Y.;Yen, C.-J.;Al-Batran, S.-E.;Ferry, D.;Gao, L.;Hsu, Y.;Cheng, R.;Orlando, M.;Ohtsu, A. |
| 國立成功大學 |
2018 |
Hepatocellular carcinoma–related cyclin D1 is selectively regulated by autophagy degradation system
|
Wu, S.-Y.;Lan, S.-H.;Wu, S.-R.;Chiu, Y.-C.;Lin, X.-Z.;Su, I.-J.;Tsai, Tsai T.-F.;Yen, C.-J.;Lu, T.-H.;Liang, F.-W.;Li, C.-Y.;Su, H.-J.;Su, C.-L.;Liu, H.-S. |
| 國立成功大學 |
2018 |
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: An analysis of the phase 3 REACH study
|
Chau, I.;Park, J.O.;Ryoo, B.-Y.;Yen, C.-J.;Poon, R.;Pastorelli, D.;Blanc, J.-F.;Kudo, M.;Pfiffer, T.;Hatano, E.;Chung, H.C.;Kopeckova, Kopeckova K.;Phelip, J.-M.;Brandi, G.;Ohkawa, S.;Li, C.-P.;Okusaka, T.;Hsu, Y.;Abada, P.B.;Zhu, A.X. |
| 國立成功大學 |
2018 |
A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma
|
Yen, C.-J.;Kim, T.-Y.;Feng, Y.-H.;Chao, Y.;Lin, D.-Y.;Ryoo, B.-Y.;Huang, D.C.-L.;Schnell, D.;Hocke, J.;Loemb�, A.-B.;Cheng, A.-L. |
| 國立成功大學 |
2017-12-01 |
Hydrogen gas protects IP3Rs by reducing disulfide bridges in human keratinocytes under oxidative stress
|
Wu, C.-Y.;Hsu, W.-L.;Tsai, M.-H.;Liang, J.-L.;Lu, J.-H.;Yen, C.-J.;Yu, H.-S.;Noda, M.;Lu, C.-Y.;Chen, C.-H.;Yan, S.-J.;Yoshioka, T.; 顏賢章 |
| 臺大學術典藏 |
2017 |
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
|
Di Laurenzio L.; Lee R.; Larson S.M.; Cheng A.-L.; Carrasquilo J.A.; Ohishi N.; Chen Y.-C.; Agajanov T.; Boisserie F.; Morikawa H.; Maki Y.; Tanaka T.; Ohtomo T.; Schwartz L.; Smith-Jones P.M.; Frenette C.; O’Neil B.; Shao Y.-Y.; Wan P.; Ma J.; Gansukh B.; Lyashchenko S.K.; Pandit-Taskar N.; Ruan S.; Beylergil V.; O’Donoghue J.; Yen C.-J.; CHIH-HUNG HSU; Abou-Alfa G.K.; Abou-Alfa G.K.;Yen C.-J.;Chih-Hung Hsu;O’Donoghue J.;Beylergil V.;Ruan S.;Pandit-Taskar N.;Gansukh B.;Lyashchenko S.K.;Ma J.;Wan P.;Shao Y.-Y.;Lin Z.-Z.;Frenette C.;O’Neil B.;Schwartz L.;Smith-Jones P.M.;Ohtomo T.;Tanaka T.;Morikawa H.;Maki Y.;Ohishi N.;Chen Y.-C.;Agajanov T.;Boisserie F.;Di Laurenzio L.;Lee R.;Larson S.M.;Cheng A.-L.;Carrasquilo J.A.; Lin Z.-Z. |
| 國立成功大學 |
2017 |
Investigating the association between diet and risk of head and neck cancer in Taiwan
|
Chang, Chang C.-C.;Lee, W.-T.;Lee, Y.-C.;Huang, C.-C.;Ou, C.Y.;Lin, Y.-H.;Huang, J.-S.;Wong, T.-Y.;Chen, K.-C.;Hsiao, J.-R.;Lu, Y.-C.;Tsai, S.-T.;Lai, Y.-H.;Wu, Y.-H.;Hsueh, W.-T.;Yen, C.-J.;Wu, S.-Y.;Chang, J.-Y.;Fang, S.-Y.;Wu, J.-L.;Lin, C.-L.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
| 國立成功大學 |
2017 |
Investigating the Association between Alcohol and Risk of Head and Neck Cancer in Taiwan
|
Huang, C.-C.;Hsiao, J.-R.;Lee, W.-T.;Lee, Y.-C.;Ou, C.-Y.;Chang, Chang C.-C.;Lu, Y.-C.;Huang, J.-S.;Wong, T.-Y.;Chen, K.-C.;Tsai, S.-T.;Fang, S.-Y.;Wu, J.-L.;Wu, Y.-H.;Hsueh, W.-T.;Yen, C.-J.;Wu, S.-Y.;Chang, J.-Y.;Lin, C.-L.;Wang, Y.-H.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
| 國立成功大學 |
2017 |
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
|
Abou-Alfa, G.K.;Yen, C.-J.;Hsu, C.-H.;O’Donoghue, J.;Beylergil, V.;Ruan, S.;Pandit-Taskar, N.;Gansukh, B.;Lyashchenko, S.K.;Ma, J.;Wan, P.;Shao, Y.-Y.;Lin, Z.-Z.;Frenette, C.;O’Neil, B.;Schwartz, L.;Smith-Jones, P.M.;Ohtomo, T.;Tanaka, Tanaka T.;Morikawa, H.;Maki, Y.;Ohishi, N.;Chen, Y.-C.;Agajanov, T.;Boisserie, F.;Di, Laurenzio L.;Lee, R.;Larson, S.M.;Cheng, A.-L.;Carrasquilo, J.A. |
| 國立成功大學 |
2017 |
Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan
|
Shen, W.-C.;Chen, J.-S.;Shao, Y.-Y.;Lee, K.-D.;Chiou, T.-J.;Sung, Y.-C.;Rau, K.-M.;Yen, C.-J.;Liao, Y.-M.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Hwang, W.-L.;Lai, P.-Y.;Chang, Chang C.-S.;Chou, W.-C.;Hsieh, R.-K. |
| 國立成功大學 |
2016-06 |
Exposure-Response relationship of second-line ramucirumab in East Asian patients with advanced gastric cancer from RAINBOW, a global, randomized, double-blind, phase 3 study
|
Kim, T. Y.;Yen, C. -J.;Al-Batran, S. -E.;Gao, L.;Ferry, D.;Hsu, Y.;Cheng, R.;Orlando, M.;Ohtsu, A. |
| 臺大學術典藏 |
2016 |
Interplay between Superoxide Dismutase, Glutathione Peroxidase, and Peroxisome Proliferator Activated Receptor Gamma Polymorphisms on the Risk of End-Stage Renal Disease among Han Chinese Patients
|
Chao C.-T.; Chen Y.-C.; Chiang C.-K.; Huang J.-W.; CHENG-CHUNG FANG; Chang C.-C.; Yen C.-J. |
| 臺大學術典藏 |
2016 |
Interplay between Superoxide Dismutase, Glutathione Peroxidase, and Peroxisome Proliferator Activated Receptor Gamma Polymorphisms on the Risk of End-Stage Renal Disease among Han Chinese Patients
|
Chao C.-T.; Chen Y.-C.; Chiang C.-K.; JENQ-WEN HUANG; Fang C.-C.; Chang C.-C.; Yen C.-J. |
| 國立成功大學 |
2015-12-01 |
Phase 3 trial of pembrolizumab as a first-line treatment in subjects with recurrent/metastatic head and neck squamous cell carcinoma: KEYNOTE-048
|
Yen, C. J.; Klochikhin, A.; Cohen, E.; Vermorken, J.; Harrington, K.; Tahara, M.; Ge, Y.; Geib, J.; Jin, F.; Burtness, B. |
| 國立成功大學 |
2015-12-01 |
A clinical survey on satisfaction of pain management in hospitalized patients with cancer in Taiwan
|
Lin, J.; Chang, C. -S.; Lee, M. -Y.; Liao, Y. -M.; Wu, M. -F.; Sung, Y. -C.; Rau, K. -M.; Yu, M. -S.; Lai, P. -Y.; Chiou, T. -J.; Chen, J. -S.; Lee, K. -D.; Hwang, W. -L.; Liu, T. -C.; Yen, C. -J.; Shao, Y. -Y.; Hsieh, R. -K. |
| 國立成功大學 |
2015-12-01 |
Impact and predictive factor of undertreatment of analgesic drug in outpatients with cancer: a nationwide of clinical pain survey in Taiwan
|
Yang, C. -K.; Chou, W. -C.; Shen, W. -C.; Chen, J. -S.; Lee, K. -D.; Yen, C. -J.; Lai, P. -Y.; Shao, Y. -Y.; Hwang, W. -L.; Chiou, T. -J.; Sung, Y. -C.; Rau, K. -M.; Liao, Y. -M.; Chang, C. S.; Wu, M. -F.; Lee, M. -Y.; Yu, M. -S.; Liu, T. -C.; Hsieh, R. -K. |
| 國立成功大學 |
2015-09 |
Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment
|
Chau, I.; Park, J. O.; Ryoo, B. Y.; Yen, C. J.; Poon, R.; Pastorelli, D.; Blanc, J. F.; Kudo, M.; Pfiffer, T. F.; Hatano, E.; Chung, H. C.; Kubackova, K.; Phelip, J. M.; Brandi, G.; Ohkawa, S.; Li, C. P.; Okusaka, T.; Yang, L.; Abada, P.; Zhu, A. |
| 國立成功大學 |
2015-06-01 |
Combined analysis of two randomised Phase II trials comparing the efficacy and safety of nintedanib versus sorafenib in Caucasian and Asian patients with advanced hepatocellular carcinoma
|
Palmer, D.; Meyer, T.; Chao, Y.; Deptala, A.; Fartoux, L.; Feng, Y. -H.; Graham, J.; Lin, D. -Y.; Ma, Y. T.; Peck-Radosavljevic, M.; Ross, P.; Ryoo, B. -Y.; Yen, C. -J.; Hocke, J.; Vlassak, S.; Wenz, A.; Loembe, A. -B.; Cheng, A. -L. |
| 國立成功大學 |
2015-05-01 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, J. S.; Hsu, C.; Chiang, N. J.; Tsai, C. S.; Tsou, H. H.; Huang, S. F.; Bai, L. Y.; Chang, I. C.; Shiah, H. S.; Ho, C. L.; Yen, C. J.; Lee, K. D.; Chiu, C. F.; Rau, K. M.; Yu, M. S.; Yang, Y.; Hsieh, R. K.; Chang, J. Y.; Shan, Y. S.; Chao, Y.; Chen, L. T. |
| 國立成功大學 |
2015-03 |
Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer
|
Lee, W-T; Huang, C-C; Chen, K-C; Wong, T-Y; Ou, C-Y; Tsai, S-T; Yen, C-J; Fang, S-Y; Lo, H-I; Wu, Y-H; Hsueh, W-T; Yang, M-W; Lin, F-C; Hsiao, J-R; Huang, J-S; Chang, J-Y; Chang, K-Y; Wu, S-Y; Lin, C-L; Wang, Y-H; Weng, Y-L; Yang, H-C; Chang, J. S. |
| 臺大學術典藏 |
2015 |
Pre-surgical Geriatric Syndromes, Frailty, and Risks for Postoperative Delirium in Older Patients Undergoing Gastrointestinal Surgery: Prevalence and Red Flags
|
Chen C.C.-H.;Ming-Tsan Lin;Liang J.-T.;Chen C.-M.;Yen C.-J.;Huang G.-H.; Chen C.C.-H.; MING-TSAN LIN; Liang J.-T.; Chen C.-M.; Yen C.-J.; Huang G.-H. |
| 臺大學術典藏 |
2015 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
on behalf of the Taiwan Cooperative Oncology Group; Wei T.-C.; Shan Y.S.; Chao Y.; Chen L.-T.; Chin Y.-H.; Chung T.-R.; Yu W.-L.; Lee M.-H.; Lin L.-F.; Lin P.-C.; Wu Y.-L.; Wang H.-L.; Lu L.-J.; Chen S.-Y.; Wu C.-C.; Chang J.Y.; Yu M.S.; Yang Y.; Hsieh R.K.; Chiu C.F.; Rau K.M.; Lee K.D.; Shiah H.S.; Chang I.C.; Bai L.Y.; Huang S.F.; Tsou H.H.; Tsai C.S.; Chiang N.J.; CHIH-HUNG HSU; Chen J.S.; Chen J.S.;Chih-Hung Hsu;Chiang N.J.;Tsai C.S.;Tsou H.H.;Huang S.F.;Bai L.Y.;Chang I.C.;Shiah H.S.;Ho C.L.;Yen C.J.;Lee K.D.;Chiu C.F.;Rau K.M.;Yu M.S.;Yang Y.;Hsieh R.K.;Chang J.Y.;Shan Y.S.;Chao Y.;Chen L.-T.;Chin Y.-H.;Chung T.-R.;Yu W.-L.;Lee M.-H.;Lin L.-F.;Lin P.-C.;Wu Y.-L.;Wang H.-L.;Lu L.-J.;Chen S.-Y.;Wu C.-C.;Wei T.-C.;On Behalf Of The Taiwan Cooperative Oncology Group; Yen C.J.; Ho C.L. |
| 臺大學術典藏 |
2015 |
Viridans streptococci in peritoneal dialysis peritonitis: Clinical courses and long-term outcomes
|
Chao C.-T.; Lee S.-Y.; Yang W.-S.; Chen H.-W.; CHENG-CHUNG FANG; Yen C.-J.; Chiang C.-K.; Hung K.-Y.; Huang J.-W. |
| 臺大學術典藏 |
2015 |
miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin
|
Chen Y.-J.; Chen J.-Y.; Wang L.-Y.; Chiu S.-J.; Shih W.-L.; Ho C.-Y.; TZU-TANG WEI; Pan H.-L.; Chien P.-H.; Hung M.-C.; Chen C.-C.; Huang W.-C.; Chen W.-S.;Yen C.-J.;Chen Y.-J.;Chen J.-Y.;Wang L.-Y.;Chiu S.-J.;Shih W.-L.;Ho C.-Y.;Tzu-Tang Wei;Pan H.-L.;Chien P.-H.;Hung M.-C.;Chen C.-C.;Huang W.-C.; Chen W.-S.; Yen C.-J. |
| 臺大學術典藏 |
2015 |
Ferritin heavy chain mediates the protective effect of heme oxygenase-1 against oxidative stress
|
Cheng H.-T.;Yen C.-J.;Chang C.-C.;Huang K.-T.;Chen K.-H.;Zhang R.-Y.;Lee P.-Y.;Miaw S.-C.;Jenq-Wen Huang;Chiang C.-K.;Wu K.-D.;Hung K.-Y.; Cheng H.-T.; Yen C.-J.; Chang C.-C.; Huang K.-T.; Chen K.-H.; Zhang R.-Y.; Lee P.-Y.; Miaw S.-C.; JENQ-WEN HUANG; Chiang C.-K.; Wu K.-D.; Hung K.-Y. |
| 臺大學術典藏 |
2015 |
Visceral fat area is associated with HbA1c but not dialysate-related glucose load in nondiabetic PD patients
|
Ho L.-C.; Yen C.-J.; Chao C.-T.; Chiang C.-K.; JENQ-WEN HUANG; Hung K.-Y. |
| 臺大學術典藏 |
2015 |
Serum free 1,25-dihydroxy-vitamin D is more closely associated with fibroblast growth factor 23 than other vitamin D forms in chronic dialysis patients
|
Chao C.-T.;Lee S.-Y.;Yen C.-J.;Chiang C.-K.;Jenq-Wen Huang;Hung K.-Y.; Chao C.-T.; Lee S.-Y.; Yen C.-J.; Chiang C.-K.; JENQ-WEN HUANG; Hung K.-Y. |
| 臺大學術典藏 |
2015 |
Genome-wide association study for autism spectrum disorder in taiwanese han population
|
Kuo P.-H.; Chuang L.-C.; Su M.-H.; Chen C.-H.; Chen C.-H.; Wu J.-Y.; Yen C.-J.; Wu Y.-Y.; Liu S.-K.; Chou M.-C.; Chou W.-J.; Chiu Y.-N.; Tsai W.-C.; SUSAN SHUR-FEN GAU; Esteban F.J. |
| 國立成功大學 |
2014-05-13 |
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin, C-C; Su, W-C; Yen, C-J; Hsu, C-H; Su, W-P; Yeh, K-H; Lu, Y-S; Cheng, A-L; Huang, D. C-L; Fritsch, H.; Voss, F.; Taube, T.; Yang, J. C-H |
| 國立臺灣科技大學 |
2014 |
Heliostat design for the daylighting system
|
Chang, C.-H.;Hsiso, H.-C.;Chang, C.-M.;Wang, C.-Y.;Lin, T.-H.;Chen, Y.-Y.;Lai, Y.-L.;Yen, C.-J.;Chen, K.-Y.;Whang, A.J.-W. |
| 國立臺灣科技大學 |
2014 |
Heliostat design for the daylighting system
|
Chang, C.-H.;Hsiso, H.-C.;Chang, C.-M.;Wang, C.-Y.;Lin, T.-H.;Chen, Y.-Y.;Lai, Y.-L.;Yen, C.-J.;Chen, K.-Y.;Whang, A.J.-W. |
| 國立臺灣大學 |
2014 |
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin, C-C; Su, W-C; Yen, C-J; Hsu, C-H; Su, W-P; Yeh, K-H; Lu, Y-S; Cheng, A-L; Huang, D. C-L; Fritsch, H.; Voss, F.; Taube, T.; Yang, J. C-H; 林家齊; 楊志新; 盧彥伸; 鄭安理; 徐志宏; 葉坤輝 |
| 臺大學術典藏 |
2014 |
Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis
|
Jenq-Wen Huang;Lien Y.-C.;Yang C.-Y.;Liu K.-L.;Wu C.-F.;Yen C.-J.;Wu C.-K.;Lee J.-K.;Ho S.-R.;Wu H.-Y.;Chiang C.-K.;Cheng H.-T.;Shyu R.-S.;Hung K.-Y.; JENQ-WEN HUANG; Lien Y.-C.; Yang C.-Y.; Liu K.-L.; Wu C.-F.; Yen C.-J.; Wu C.-K.; Lee J.-K.; Ho S.-R.; Wu H.-Y.; Chiang C.-K.; Cheng H.-T.; Shyu R.-S.; Hung K.-Y. |
| 臺大學術典藏 |
2014 |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Cheng A.-L.; Yeh K.-H.; Su W.-C.; Chao Y.; Shen Y.-C.; Li C.-P.; Yen C.-J.; CHIUN HSU; Lin Y.-L.; Lin Z.-Z.; Chen L.-T. |
| 國立臺灣大學 |
2013 |
A Rare and Under-recognized Pathogen in Peritoneal Dialysis Peritonitis: Corynebacterium jeikeium
|
Chao, C. T.; Huang, J. W.; Yen, C. J.; 嚴崇仁; 趙家德; 黃政文 |
| 臺大學術典藏 |
2013 |
High peritoneal KT/V and peritonitis rates are associated with peritoneal calcification.
|
Wu C.K.; CHENG-CHUNG FANG; Liu K.L.; Yang C.Y.; Lien Y.C.; Huang J.W.; Lee J.K.; Wu H.Y.; Chiang C.K.; Cheng H.T.; Yen C.J.; Hung K.Y. |
| 臺大學術典藏 |
2013 |
Citrobacter peritoneal dialysis peritonitis: Rare occurrence with poor outcomes
|
Huang J.-W.; Hung K.-Y.; Chiang C.-K.; Yen C.-J.; CHENG-CHUNG FANG; Chen H.-W.; Yang W.-S.; Lee S.-Y.; Chao C.-T. |
| 臺大學術典藏 |
2013 |
Effect of age on febrile response in patients with healthcare-associated bloodstream infection
|
Lu S.-H.; YEE-CHUN CHEN; Chang Y.-C.; Yen C.-J.; Dai Y.-T. |
| 臺大學術典藏 |
2013 |
Citrobacter peritoneal dialysis peritonitis: Rare occurrence with poor outcomes
|
Chao C.-T.; Lee S.-Y.; Yang W.-S.; Chen H.-W.; Fang C.-C.; Yen C.-J.; Chiang C.-K.; Hung K.-Y.; JENQ-WEN HUANG |
| 國立成功大學 |
2012-03 |
A PHASE I/II STUDY OF FORETINIB, AN ORAL MULTIKINASE INHIBITOR TARGETING MET, RON, AXL, TIE-2 AND VEGFR IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
|
Yau, T.; Yen, C. -J.; Chen, P. -J.; Chau, Y.; Lencioni, R.; Kallender, H.; Ottesen, L. H.; Poon, R. T. -P. |
| 臺大學術典藏 |
2012 |
Fibrin-Induced Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelial Cells as a Mechanism of Peritoneal Fibrosis: Effects of Pentoxifylline
|
Fang C.-C.;Huang J.-W.;Shyu R.-S.;Yen C.-J.;Shiao C.-H.;Chiang C.-K.;Rey-Heng Hu;Tsai T.-J.; Fang C.-C.; Huang J.-W.; Shyu R.-S.; Yen C.-J.; Shiao C.-H.; Chiang C.-K.; REY-HENG HU; Tsai T.-J. |
| 臺大學術典藏 |
2012 |
Fibrin-Induced Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelial Cells as a Mechanism of Peritoneal Fibrosis: Effects of Pentoxifylline
|
Fang C.-C.; Huang J.-W.; Shyu R.-S.; Yen C.-J.; Shiao C.-H.; Chiang C.-K.; Hu R.-H.; TUN-JUN TSAI |
| 臺大學術典藏 |
2011 |
Modified hospital elder life program: Effects on abdominal surgery patients
|
Chen C.C.-H. ;Ming-Tsan Lin ;Tien Y.-W. ;Yen C.-J. ;Huang G.-H. ;Inouye S.K.; Chen C.C.-H.; MING-TSAN LIN; Tien Y.-W.; Yen C.-J.; Huang G.-H.; Inouye S.K. |
| 臺大學術典藏 |
2011 |
Prevalence of geriatric conditions: A hospital-wide survey of 455 geriatric inpatients in a tertiary medical center
|
Huang G.-H.; CHARLOTTE WANG; Chen C.C.H.; Yen C.-J.; Dai Y.-T. |
| 國立臺灣大學 |
2010-07 |
Prevalence of geriatric conditions: A hospital-wide survey of 455 geriatric inpatients in a tertiary medical center
|
Chen, C.C-H.; Yen, C.J.; Dai, Y.T.; Wang, Charlotte.; Huang, G.H |
| 國立臺灣大學 |
2010-07 |
Shared Risk Factors for Distinct Geriatric Syndromes in Older Taiwanese Inpatients
|
Chen, C.C.; Dai, Y.T.; Yen, C.J.; Huang, C.H.; Wang, Charlotte |
| 國立臺灣科技大學 |
2010 |
Characteristics of air pressure fluctuations in high-rise drainage stacks
|
Cheng C.L.;Mui K.W.;Wong L.T.;Yen C.J.;He K.C. |
| 亞洲大學 |
2010 |
ARD1 stabilization of TSC2 suppresses tumorigenesis via the mTOR signaling pathway
|
;Kuo, H-P;Lee, D-F;Chen, C-T;Liu, M;Chou, C-K;Lee, H-J.;Xie, X;Wei, Y.;Xia, W;Zhang, W;Yi, D;Yang, J-Y;Huang, T-H;Yen, C-J;Tan, M;Xing, G;Zhao, Y;Lin, C-H;Tsai, S-F;Fidler, IJ;洪明奇;Hung, Mien-Chie |
| 中國醫藥大學 |
2010 |
ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway
|
(Kuo, H-P); (Lee, D-F); (Chen, C-T.); (Liu, M.); (Chou, C-K.); (Lee, H. J.); (Xie, X.); (Wei, Y.); (Xia, W); (Zhang, W.); (Yi, D.); (Yang, J-Y.); (Huang, T-H); (Yen, C-J.); (Tan, M); (Xing, G); (Zhao, Y); (Lin, C-H); (Tsai, S-F); (Fidler, I. J.); 洪明奇(Mien-Chie Hung)* |
| 中國醫藥大學 |
2010 |
ARD1 stalization of TSC2 suppresses tumorigenesis via the mTOR signaling pathway
|
(Kuo, H-P); (Lee, D-F); (Chen, C-T.); (Liu, M.); (Chou, C-K.); (Lee, H. J.); (Xie, X.); (Wei, Y.); (Xia, W); (Zhang, W.); (Yi, D.); (Yang, J-Y.); (Huang, T-H); (Yen, C-J.); (Tan, M); (Xing, G); (Zhao, Y); (Lin, C-H); (Tsai, S-F); (Fidler, I. J.); 洪明奇(Mien-Chie Hung)* |
顯示項目 391-440 / 471 (共10頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
